NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.22
$1.29
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
129,678 shs
Average Volume
21.62 million shs
Market Capitalization
$52.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VTL stock logo

About Vital Therapies Stock (NASDAQ:VTL)

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

VTL Stock News Headlines

Vital Ltd VTL
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Vital Ltd.
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Best Online Therapy For Anxiety Of 2023
5 Best Online Therapy For Teens Of 2023
Occupational Therapy Assistant
Asthma & COPD Therapies Market Report 2023-2033
Vital Limited (VTL.NZ)
Vital Ltd
See More Headlines
Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.54 million
Optionable
Not Optionable
Beta
3.51
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Daniel Vitt
    President, Chief Executive Officer & Director
  • Manfred Gröppel
    Chief Operating Officer
  • Glenn Whaley
    VP-Finance, Chief Financial & Accounting Officer
  • Andreas Muehler
    Chief Medical Officer
  • Hella Kohlhof
    Chief Scientific Officer

VTL Stock Analysis - Frequently Asked Questions

How were Vital Therapies' earnings last quarter?

Vital Therapies, Inc. (NASDAQ:VTL) posted its earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.03.

What other stocks do shareholders of Vital Therapies own?
This page (NASDAQ:VTL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners